Bloom Science, Inc.

Bloom Science, Inc.

Leveraging the Gut-Brain Axis to Drive Therapeutic Innovation

Founded 2018

San Diego, United States 17 employees Series A Total: $12.00M Biopharma, Biotechnology

Bloom Science, Inc., founded in 2018, is poised at the forefront of biopharma and biotechnology innovation. By leveraging the Gut-Brain Axis, Bloom Science aims to revolutionize therapeutic development for central nervous system disorders with their proprietary IrisRx™ discovery platform.

This United States-based clinical-stage company has focused its efforts on a deep pipeline targeting rare and complex neurological diseases such as Dravet syndrome, other rare epilepsies, Amyotrophic Lateral Sclerosis (ALS), and various neurodegenerative and cognitive disorders. Their approach promises novel therapeutics characterized by superior safety profiles and the innovative use of gut commensal microbes.

Bloom Science's last financial infusion was a $12.00M Series A investment dated 01 December 2021, led by distinguished investors like Joyance Partners, Apollo Health Ventures, Bayer, Leaps by Bayer, and the ALS Investment Fund, underscoring strong investor confidence in its mission-driven approach.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$12.00M	5	Joyance Partners, Apollo Health Ventures +3	01 Dec 2021
Round	Undisclosed	2	Joyance Partners, Social Starts	01 Mar 2020
Seed	Undisclosed	1	Social Starts	01 May 2018
Spinout	Undisclosed	1	University of California, Los Angeles	01 Jan 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$12.00M

Joyance Partners, Apollo Health Ventures +3

01 Dec 2021

Round

Undisclosed

Joyance Partners, Social Starts

01 Mar 2020

Seed

Undisclosed

Social Starts

01 May 2018

Spinout

Undisclosed

University of California, Los Angeles

01 Jan 2018

FAQ About Bloom Science, Inc.

Leveraging the Gut-Brain Axis to Drive Therapeutic Innovation

Bloom Science, Inc. was founded in 2018.

Bloom Science, Inc. is headquartered in San Diego, United States.

Bloom Science, Inc. operates in Biopharma and Biotechnology. Its work centres on Gut-Brain Axis, Therapeutic Innovation, Central Nervous System and Rare Neurological Disorders. Its customers include Patients with unmet needs in metabolic and neurological health, Healthcare professionals and Biopharma partners.

Bloom Science, Inc. has approximately 17 employees.

Bloom Science, Inc. has completed 4 funding rounds, raising a total of $12.00M. The latest funding stage is Series A.

Bloom Science, Inc. offers: Development of novel biotherapeutics, Clinical research and trials, Discovery and development of gut microbiome-based treatments.

Top alternatives and competitors to Bloom Science, Inc. include Enterin Inc., Vertero Therapeutics, Inc., Emalex Biosciences, Bloomsbury Genetic Therapies, Glyscend Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Bloom Science, Inc. and Enterin Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Bloom Science, Inc.

Services & Products

Target Customers

Funding Rounds & Investors (4)

Bloom Science, Inc. Alternatives & Competitors

FAQ About Bloom Science, Inc.